Table 8. | Characteristics of combined treatment |
| Study | Population | Gender | Age | Study group |
Observation period |
Treatment outcome | Results | Conclusions |
|---|---|---|---|---|---|---|---|---|
| Male/female | Years | Months | ||||||
| Eguchi et al. [16] | Patients diagnosed with stage 2 MRONJ and treated with non-surgical or surgical therapy |
Surgical: 13/15 |
Surgical: 72.3 (SD 11.3) |
Surgical (n = 28): necrotic bone resection until the bone tissue's vascularization was established | 6 |
Success-complete absence of exposed bone without any clinical symptoms.
Failure- bone exposure remaining or disease progress |
Surgical: 25 success, 3 failure |
In comparison to non-surgical treatment, surgical treatment for stage 2 MRONJ improved efficacy (P < 0.01) |
|
Non-surgical: 9/15 |
Non-surgical: 74.8 (SD 10.3) |
Non-surgical (n = 24): antibiotics and analgesics, as well as professional oral hygiene management by a dental hygienist |
Non-surgical: 8 success, 16 failure |
|||||
| El-Rabbany et al. [19] | Patients diagnosed with stage 1 - 3 MRONJ and treated with non-surgical or surgical therapy |
Surgical: 9/47 |
Surgical: 79 |
Surgical (n = 56): debridement, curettage, sequestrectomy, saucerization and resection |
Surgical: 15.5 |
Treatment was considered successful if had absence of pain and absence of exposed or probable bone. |
Surgical: 39 healed (70%), 17 unhealed (30%) |
Compared to non-surgical therapy, surgical therapy was substantially related with higher odds of resolution |
|
Non-surgical: 5/17 |
Non-surgical: 82 |
Non-surgical (n = 22): local and/or systemic antimicrobial therapy, pentoxifylline, hyperbaric oxygen and teriparatide |
Non-surgical: 11 |
Non-surgical: 8 healed (36%), 14 unhealed (64%) |
MRONJ = medication-related osteonecrosis of the jaw; SD = standard deviation. |
.png)
.png)
.png)
.png)
.png)
.png)
.png)